Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ibrahim Dahbour"'
Autor:
Bo Zhao, Chan Shen, Ibrahim Dahbour, Maen Abdelrahim, Joanna Grace M. Manzano, Jaya Sheela Amaram-Davila, Valda D. Page, Alvin H. Moss, Juhee Song, Ala Abudayyeh, Sriram Yennu, Marina George, Shouhao Zhou, Sreedhar Mandayam, Rima N. Pai, Joseph L. Nates
Publikováno v:
Am J Hosp Palliat Care
Introduction: In patients with advanced cancer, prolongation of life with treatment often incurs substantial emotional and financial expense. Among hospitalized patients with cancer since acute kidney injury (AKI) is known to be associated with much
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b54648036bc2c318592afe9301e271c
https://europepmc.org/articles/PMC7363512/
https://europepmc.org/articles/PMC7363512/
Autor:
Kenna R. Shaw, Aziz Tabash, Lianchun Xiao, Ahmed O.S. Abousamra, Reham Abdel-Wahab, Ibrahim Dahbour, Benjamin R. Kipp, Robert R. McWilliams, Jeremy Clifton Jones, Amr S. Soliman, Humaid O. Al-Shamsi, Robert A. Wolff, Manal M. Hassan, Yazan Fahmawi, Scott Kopetz
Publikováno v:
Journal of Gastrointestinal Oncology. 7:882-902
Background: The frequency rates of mutations such as KRAS, NRAS, BRAF, and PIK3CA in colorectal cancer (CRC) differ among populations. The aim of this study was to assess mutation frequencies in the Arab population and determine their correlations wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fb57aba55cadc05be4b1214938f3995
https://doi.org/10.21037/jgo.2016.11.02
https://doi.org/10.21037/jgo.2016.11.02
Autor:
Humaid O, Al-Shamsi, Jeremy, Jones, Yazan, Fahmawi, Ibrahim, Dahbour, Aziz, Tabash, Reham, Abdel-Wahab, Ahmed O S, Abousamra, Kenna R, Shaw, Lianchun, Xiao, Manal M, Hassan, Benjamin R, Kipp, Scott, Kopetz, Amr S, Soliman, Robert R, McWilliams, Robert A, Wolff
Publikováno v:
Journal of gastrointestinal oncology. 7(6)
The frequency rates of mutations such asArab patients from the Arab Gulf region and a population of age- and sex-matched Western patients with CRC whose tumors were evaluated with next-generation sequencing (NGS) were identified and retrospectively r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f116baa372ec74b85af4f37d95dace62
https://pubmed.ncbi.nlm.nih.gov/28078112
https://pubmed.ncbi.nlm.nih.gov/28078112
Autor:
Reham Abdel-Wahab, Ahmed Omar Kaseb, Thomas A. Aloia, Mohamed Abdelsalam, Rony Avritscher, Manal Hassan, Jean Nicolas Vauthey, Ravi Murthy, Hesham M. Amin, Bruno C. Odisio, Sahin Lacin, Armeen Mahvash, Ahmed S Shalaby, Claudius Conrad, Sunil Krishnan, Asif Rashid, Prajnan Das, Humaid O. Al-Shamsi, James C. Yao, Eugene J. Koay, Ibrahim Dahbour, Yun Shin Chun
Background: Hepatocellular carcinoma (HCC) prognosis depends on clinicopathological features in addition to the treatment provided. We aimed to assess the natural history of TNM stage I HCC tumors which received different treatment over a period of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7e8b12eec869178fa875fb51c19cce
https://europepmc.org/articles/PMC6743737/
https://europepmc.org/articles/PMC6743737/
Autor:
Tara Sagebiel, Yazan Fahmawi, Humaid O. Al-Shamsi, Jeannette E. Mares, Jaffer A. Ajani, Prajnan Das, Aziz Tabash, Catherine E Devine, Quan D. Lin, Mariela A. Blum, Jeannelyn S. Estrella, Ibrahim Dahbour, Aurelio Matamoros, Brian D. Badgwell, Jane E. Rogers
Background: Despite the wide spread use of trastuzumab in human epidermal growth factor receptor 2 (HER2) overexpressing metastatic gastric cancer patients, its optimal duration of administration beyond first-line disease progression is unknown. In H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b64b9f6d980f5d0cae042320e89a4d9
https://europepmc.org/articles/PMC4963369/
https://europepmc.org/articles/PMC4963369/
Autor:
Sriram Yennu, Ibrahim Dahbour, Bo Zhao, Maen Abdelrahim, Ala Abudayyeh, Chan Shen, Valda D. Page, Alvin H. Moss, Rima Pai, Shouhao Zhou, Marina George, Joanna-Grace Manzano, Joseph L. Nates
Publikováno v:
Journal of Clinical Oncology. 34:55-55
55 Background: Retrospective study of the outcomes of Stage IV Cancer Patients with End Stage Renal disease Receiving Dialysis and comparing the survival benefits among the patients who received Hemodialysis versus who didn’t at a Comprehensive Can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de0ecba77a1a3e72af322fe79bb6d391
https://doi.org/10.1200/jco.2016.34.26_suppl.55
https://doi.org/10.1200/jco.2016.34.26_suppl.55
Autor:
Jane E. Rogers, Jaffer A. Ajani, Mariela A. Blum, Yazan Fahmawi, Jeannette E. Mares, Humaid O. Al-Shamsi, Ibrahim Dahbour, Quan Lin
Publikováno v:
Journal of Clinical Oncology. 34:e15560-e15560
e15560Background: Despite the widespread use of trastuzumab in the management of patients with Human Epidermal growth factor receptors (HER2) - overexpressing metastatic gastric cancer, its optimal...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588631a8453b1c2ae94a302f10fea3f3
https://doi.org/10.1200/jco.2016.34.15_suppl.e15560
https://doi.org/10.1200/jco.2016.34.15_suppl.e15560